BOHLIN GAREN G 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 12, 2023
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Purchase
Common Stock
2023-09-12$1.22/sh+41,140$49,985→ 45,140 total
Footnotes (1)
- [F1]Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.1935 to $1.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price..